HK Stock Market Move | TH MEDICAL-B (02697) surged over 18% in early trading as the company was included in the Hang Seng Composite Index, and it is expected to enter the Stock Connect list in the future.

TH MEDICAL-B (02697) rose over 18% in early trading, closing up 14.52% at HKD 765, with a trading volume of HKD 21.4048 million. In news, the Hang Seng Index Company announced the results of its quarterly review, where Zhenjiankang Medical was included in the Hang Seng Composite Index. The changes to the Hang Seng Composite Index will be implemented after the market closes on September 4 (Friday) and will take effect on September 7 (Monday), at which point the Shanghai and Shenzhen stock exchanges will adjust the scope of investable stocks under the Hong Kong Stock Connect accordingly. Zhenjiankang Medical may be included in the Hong Kong Stock Connect due to meeting a series of criteria, including market capitalization and liquidity. It is worth noting that recently, Zhenjiankang Medical's independently developed organ normothermic perfusion system officially won the bid for Yunnan Agricultural Universitys "Procurement Project for Scientific Research Equipment for the Key Laboratory of Gene Editing and Xenogeneic Organ Transplantation in Small Pigs, No. 2026-73," with a transaction amount of 2.8 million yuan. This marks that Zhenjiankang Medical's normothermic multi-organ perfusion platform has fully passed engineering verification and cutting-edge application scenario validation.